- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 2.4 Settlement Agreement and Mutual Release
- 2.5 Amendment to Securities Purchase Agreement
- 2.6 Amendment to License Agreement
- 10.18 Severance Agreement and Release for Jeffrey Landau
- 10.24 License Agreement Dated Oct. 15, 2004 BTWN Biomarin and DSP
- 10.25 License Agreement Dated July 30, 2004 BTWN Biomarin and DSP
- 10.26 Supply Agreement Dated July 30, 2004 BTWN Biomarin and DSP
- 10.37 Second Agreement to Loan and Security Agreement
- 10.38 Convertible Promissory Note Dated Jan 12, 2005
- 10.39 Cro Services Agreement Dated Sep. 15, 2004
- 21.1 List of Subsidiaries
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO and CFO (Section 906)
- 31.2 CFO Certification
- 32.1 Certification of CEO and CFO (Section 906)
- 99.1 Biomarin/genzyme LLC Financial Statements
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of BioMarin Pharmaceutical Inc. (the “Company”) for the year ended December 31, 2004, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we Louis Drapeau, as Chief Executive Officer of the Company, and Jeffrey H. Cooper, as Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ LOUIS DRAPEAU |
Louis Drapeau |
Chief Executive Officer |
March 15, 2005 |
/s/ JEFFREY H. COOPER |
Jeffrey H. Cooper |
Chief Financial Officer |
March 15, 2005 |